Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasuya Inomata
Treat-And-Extend Versus Every-Other-Month Regimens With Aflibercept in Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Related publications
Treat-And-Extend Versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Efficacy and Safety of Intravitreal Aflibercept Treat-And-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- And 96-Week Findings From ALTAIR
Advances in Therapy
Medicine
Pharmacology
Comment on ‘Transitioning to Intravitreal Aflibercept Following a Previous Treat-And-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: 24-Month Results’
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Two-Year Outcome of Treat-And-Extend Aflibercept After Ranibizumab in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients
Clinical Ophthalmology
Ophthalmology
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
Treat-And-Extend Therapy Using Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: 2-Year Real-World Practice Data From Slovenia
BMC Ophthalmology
Medicine
Ophthalmology
Outcomes When Switching From a Pro Re Nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration
Ophthalmologica
Medicine
Ophthalmology
Sensory Systems
Switching Frompro Re Natato Treat-And-Extend Regimen Improves Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-And-Extend Regimen
Ophthalmic Surgery Lasers and Imaging Retina
Medicine
Ophthalmology
Surgery
